Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4284 | 1813 | 28.6 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
98 | 3 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//SURGERY | 75394 |
93 | 2 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//KIDNEY TRANSPLANTATION | 26351 |
4284 | 1 | MYCOPHENOLIC ACID//MYCOPHENOLATE MOFETIL//MYCOPHENOLIC ACID GLUCURONIDE | 1813 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MYCOPHENOLIC ACID | authKW | 5007123 | 26% | 62% | 476 |
2 | MYCOPHENOLATE MOFETIL | authKW | 2131019 | 24% | 30% | 429 |
3 | MYCOPHENOLIC ACID GLUCURONIDE | authKW | 690469 | 2% | 100% | 41 |
4 | ENTERIC COATED MYCOPHENOLATE SODIUM | authKW | 426606 | 2% | 67% | 38 |
5 | LIMITED SAMPLING STRATEGY | authKW | 270715 | 2% | 37% | 43 |
6 | MYCOPHENOLATE SODIUM | authKW | 256699 | 1% | 61% | 25 |
7 | MYCOPHENOLATE | authKW | 232441 | 3% | 29% | 47 |
8 | MPAG | authKW | 153096 | 1% | 91% | 10 |
9 | MYFORTIC R | authKW | 151566 | 0% | 100% | 9 |
10 | INOSINE MONOPHOSPHATE DEHYDROGENASE | authKW | 148213 | 1% | 35% | 25 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Transplantation | 84785 | 45% | 1% | 813 |
2 | Medical Laboratory Technology | 9539 | 12% | 0% | 221 |
3 | Surgery | 9514 | 39% | 0% | 711 |
4 | Immunology | 8860 | 34% | 0% | 618 |
5 | Pharmacology & Pharmacy | 3677 | 28% | 0% | 502 |
6 | Toxicology | 1790 | 10% | 0% | 182 |
7 | Urology & Nephrology | 1310 | 8% | 0% | 154 |
8 | Rheumatology | 76 | 1% | 0% | 27 |
9 | Biochemical Research Methods | 72 | 3% | 0% | 56 |
10 | Chemistry, Analytical | 70 | 4% | 0% | 77 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KLIN CHEM ABT | 73589 | 1% | 19% | 23 |
2 | LUDWIG BOLTZMANN CARDIOTHORAC | 50516 | 0% | 50% | 6 |
3 | U850 | 46765 | 1% | 28% | 10 |
4 | NEPHROL RENAL TRANSPLANTAT | 45563 | 2% | 8% | 32 |
5 | CANC BIOSTAT BLOOD MARROW TRANSPLANTAT | 33681 | 0% | 100% | 2 |
6 | CARDIOTHORAC SURG CLIN BIOCHEM | 33681 | 0% | 100% | 2 |
7 | CLIN PHARMACOL PEDIAT PHARMACOL | 33681 | 0% | 100% | 2 |
8 | IDM SERV | 33681 | 0% | 100% | 2 |
9 | PHARMACOGENOM ONCOL MOL ENDOCRINOL | 33681 | 0% | 100% | 2 |
10 | SERV FARMACOL TOXICOL | 33681 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THERAPEUTIC DRUG MONITORING | 109724 | 9% | 4% | 156 |
2 | TRANSPLANTATION PROCEEDINGS | 61553 | 21% | 1% | 382 |
3 | TRANSPLANTATION | 18092 | 8% | 1% | 141 |
4 | CLINICAL TRANSPLANTATION | 16807 | 3% | 2% | 61 |
5 | PEDIATRIC TRANSPLANTATION | 4927 | 1% | 1% | 26 |
6 | TRANSPLANTATION REVIEWS | 4546 | 0% | 4% | 7 |
7 | CLINICAL PHARMACOKINETICS | 4430 | 1% | 1% | 25 |
8 | AMERICAN JOURNAL OF TRANSPLANTATION | 4047 | 2% | 1% | 34 |
9 | JOURNAL OF CLINICAL PHARMACOLOGY | 3532 | 2% | 1% | 34 |
10 | TRANSPLANT IMMUNOLOGY | 3306 | 1% | 1% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MYCOPHENOLIC ACID | 5007123 | 26% | 62% | 476 | Search MYCOPHENOLIC+ACID | Search MYCOPHENOLIC+ACID |
2 | MYCOPHENOLATE MOFETIL | 2131019 | 24% | 30% | 429 | Search MYCOPHENOLATE+MOFETIL | Search MYCOPHENOLATE+MOFETIL |
3 | MYCOPHENOLIC ACID GLUCURONIDE | 690469 | 2% | 100% | 41 | Search MYCOPHENOLIC+ACID+GLUCURONIDE | Search MYCOPHENOLIC+ACID+GLUCURONIDE |
4 | ENTERIC COATED MYCOPHENOLATE SODIUM | 426606 | 2% | 67% | 38 | Search ENTERIC+COATED+MYCOPHENOLATE+SODIUM | Search ENTERIC+COATED+MYCOPHENOLATE+SODIUM |
5 | LIMITED SAMPLING STRATEGY | 270715 | 2% | 37% | 43 | Search LIMITED+SAMPLING+STRATEGY | Search LIMITED+SAMPLING+STRATEGY |
6 | MYCOPHENOLATE SODIUM | 256699 | 1% | 61% | 25 | Search MYCOPHENOLATE+SODIUM | Search MYCOPHENOLATE+SODIUM |
7 | MYCOPHENOLATE | 232441 | 3% | 29% | 47 | Search MYCOPHENOLATE | Search MYCOPHENOLATE |
8 | MPAG | 153096 | 1% | 91% | 10 | Search MPAG | Search MPAG |
9 | MYFORTIC R | 151566 | 0% | 100% | 9 | Search MYFORTIC+R | Search MYFORTIC+R |
10 | INOSINE MONOPHOSPHATE DEHYDROGENASE | 148213 | 1% | 35% | 25 | Search INOSINE+MONOPHOSPHATE+DEHYDROGENASE | Search INOSINE+MONOPHOSPHATE+DEHYDROGENASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | STAATZ, CE , TETT, SE , (2007) CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF MYCOPHENOLATE IN SOLID ORGAN TRANSPLANT RECIPIENTS.CLINICAL PHARMACOKINETICS. VOL. 46. ISSUE 1. P. 13-58 | 173 | 93% | 216 |
2 | STAATZ, CE , TETT, SE , (2014) PHARMACOLOGY AND TOXICOLOGY OF MYCOPHENOLATE IN ORGAN TRANSPLANT RECIPIENTS: AN UPDATE.ARCHIVES OF TOXICOLOGY. VOL. 88. ISSUE 7. P. 1351 -1389 | 157 | 68% | 25 |
3 | ABD RAHMAN, AN , TETT, SE , STAATZ, CE , (2013) CLINICAL PHARMACOKINETICS AND PHARMACODYNAMICS OF MYCOPHENOLATE IN PATIENTS WITH AUTOIMMUNE DISEASE.CLINICAL PHARMACOKINETICS. VOL. 52. ISSUE 5. P. 303-331 | 139 | 78% | 10 |
4 | ABD RAHMAN, AN , TETT, SE , STAATZ, CE , (2014) HOW ACCURATE AND PRECISE ARE LIMITED SAMPLING STRATEGIES IN ESTIMATING EXPOSURE TO MYCOPHENOLIC ACID IN PEOPLE WITH AUTOIMMUNE DISEASE?.CLINICAL PHARMACOKINETICS. VOL. 53. ISSUE 3. P. 227 -245 | 115 | 96% | 2 |
5 | KUYPERS, DRJ , LE MEUR, Y , CANTAROVICH, M , TREDGER, MJ , TETT, SE , CATTANEO, D , TONSHOFF, B , HOLT, DW , CHAPMAN, J , VAN GELDER, T , (2010) CONSENSUS REPORT ON THERAPEUTIC DRUG MONITORING OF MYCOPHENOLIC ACID IN SOLID ORGAN TRANSPLANTATION.CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 5. ISSUE 2. P. 341 -358 | 98 | 88% | 92 |
6 | KNIGHT, SR , MORRIS, PJ , (2008) DOES THE EVIDENCE SUPPORT THE USE OF MYCOPHENOLATE MOFETIL THERAPEUTIC DRUG MONITORING IN CLINICAL PRACTICE? A SYSTEMATIC REVIEW.TRANSPLANTATION. VOL. 85. ISSUE 12. P. 1675-1685 | 85 | 94% | 74 |
7 | VAN GELDER, T , LI, PM , SHUKER, N , HESSELINK, DA , VAN SCHAIK, RHN , ZHANG, XL , (2014) DO ASIAN RENAL TRANSPLANT PATIENTS NEED ANOTHER MYCOPHENOLATE MOFETIL DOSE COMPARED WITH CAUCASIAN OR AFRICAN AMERICAN PATIENTS?.TRANSPLANT INTERNATIONAL. VOL. 27. ISSUE 10. P. 994 -1004 | 71 | 88% | 3 |
8 | COX, VC , ENSOM, MHH , (2003) MYCOPHENOLATE MOFETIL FOR SOLID ORGAN TRANSPLANTATION: DOES THE EVIDENCE SUPPORT THE NEED FOR CLINICAL PHARMACOKINETIC MONITORING?.THERAPEUTIC DRUG MONITORING. VOL. 25. ISSUE 2. P. 137-157 | 79 | 91% | 90 |
9 | DE WINTER, BCM , MATHOT, RAA , VAN HEST, RM , VAN GELDER, T , (2007) THERAPEUTIC DRUG MONITORING OF MYCOPHENOLIC ACID: DOES IT IMPROVE PATIENT OUTCOME?.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 3. ISSUE 2. P. 251-261 | 75 | 93% | 18 |
10 | VAN HEST, RM , HESSELINK, DA , VULTO, AG , MATHOT, RAA , VAN GELDER, T , (2006) INDIVIDUALISATION OF MYCOPHENOLATE MOFETIL DOSE IN RENAL TRANSPLANT RECIPIENTS.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 7. ISSUE 4. P. 361-376 | 86 | 83% | 14 |
Classes with closest relation at Level 1 |